ACM
Armbruster Capital Management Portfolio holdings
AUM
$552M
This Quarter Return
+2.51%
1 Year Return
+14.32%
3 Year Return
+44.28%
5 Year Return
+79.81%
10 Year Return
–
AUM
$155M
AUM Growth
+$155M
(+5.6%)
Cap. Flow
+$4.73M
Cap. Flow
% of AUM
3.06%
Top 10 Holdings %
Top 10 Hldgs %
69.84%
Holding
344
New
40
Increased
28
Reduced
72
Closed
60
Top Buys
| 1 |
Schwab International Equity ETF
SCHF
|
$3.61M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
$1.16M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$1.13M |
| 4 |
M&T Bank
MTB
|
$519K |
| 5 |
iShares Core S&P Mid-Cap ETF
IJH
|
$373K |
Top Sells
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
$706K |
| 2 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
$457K |
| 3 |
iShares MSCI EAFE ETF
EFA
|
$292K |
| 4 |
Colgate-Palmolive
CL
|
$242K |
| 5 |
SPDR Dow Jones International Real Estate ETF
RWX
|
$212K |
Sector Composition
| 1 | Technology | 2.67% |
| 2 | Healthcare | 2.57% |
| 3 | Consumer Staples | 2.51% |
| 4 | Energy | 1.98% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Philip Morris
PM
$260B
| $723K | 0.47% |
7,112
-125
| -2% | -$12.7K |
|
|
WBA
27
DELISTED
Walgreens Boots Alliance
WBA
| $625K | 0.4% |
7,500
| – | – |
|
28
AT&T
T
$209B
| $589K | 0.38% |
13,638
-2,419
| -15% | -$104K |
|
29
Berkshire Hathaway Class B
BRK.B
$1.09T
| $571K | 0.37% |
3,941
| – | – |
|
30
JPMorgan Chase
JPM
$829B
| $548K | 0.35% |
8,821
| – | – |
|
31
Johnson & Johnson
JNJ
$427B
| $538K | 0.35% |
4,438
+30
| +0.7% | +$3.64K |
|
|
32
M&T Bank
MTB
$31.5B
| $519K | 0.34% |
+4,389
| New | +$519K |
|
33
Schwab US Mid-Cap ETF
SCHM
$12.1B
| $514K | 0.33% |
12,242
-265
| -2% | -$11.1K |
|
34
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.72B
| $505K | 0.33% |
5,425
-425
| -7% | -$39.6K |
|
35
Coca-Cola
KO
$297B
| $475K | 0.31% |
10,476
+3,067
| +41% | +$139K |
|
36
Constellation Brands
STZ
$28.5B
| $463K | 0.3% |
2,800
| – | – |
|
37
Amgen
AMGN
$155B
| $461K | 0.3% |
3,028
| – | – |
|
38
Procter & Gamble
PG
$368B
| $448K | 0.29% |
5,290
+571
| +12% | +$48.4K |
|
39
Schwab US Broad Market ETF
SCHB
$36.2B
| $401K | 0.26% |
7,976
+18
| +0.2% | +$905 |
|
40
Microsoft
MSFT
$3.77T
| $391K | 0.25% |
7,645
-489
| -6% | -$25K |
|
|
41
Colgate-Palmolive
CL
$67.9B
| $383K | 0.25% |
5,235
-3,305
| -39% | -$242K |
|
42
Schwab US REIT ETF
SCHH
$8.37B
| $379K | 0.25% |
8,714
+1,085
| +14% | +$47.2K |
|
43
Bristol-Myers Squibb
BMY
$96B
| $371K | 0.24% |
5,043
| – | – |
|
44
Chevron
CVX
$324B
| $366K | 0.24% |
3,494
-337
| -9% | -$35.3K |
|
45
CVS Health
CVS
$92.8B
| $359K | 0.23% |
3,750
| – | – |
|
46
3M
MMM
$82.8B
| $348K | 0.23% |
1,990
-50
| -2% | -$8.74K |
|
47
Vanguard Small-Cap ETF
VB
$66.4B
| $340K | 0.22% |
2,937
| – | – |
|
48
Merck
MRK
$210B
| $329K | 0.21% |
5,713
-288
| -5% | -$16.6K |
|
49
Digimarc
DMRC
$188M
| $320K | 0.21% |
10,000
| – | – |
|
50
Eastman Chemical
EMN
$8.08B
| $309K | 0.2% |
4,550
| – | – |
|